血小板糖蛋白V自身抗体和补充C3与系统性红血狼的血栓形成有关
Anders A Bengtsson1, Elsa Grenmyr1, Andreas Jönsen1
1Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund.
Haematologica
|February 26, 2026
概括
血小板特异性自身抗体,特别是抗GPV,在全身性红斑狼 (SLE) 患者中很常见,并与补充C3一起,独立预测血栓事件,为SLE相关的心血管风险提供新的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 心血管研究研究心血管研究
背景情况:
- 系统性红斑狼 (SLE) 与心血管疾病风险增加有关,超过传统风险因素解释的风险.
- 血小板特异性葡萄糖蛋白 (GP) 自抗体和抗脂抗体 (aPL) 涉及到SLE的发病,但需要进一步调查.
研究的目的:
- 在SLE患者中确定血小板特异性GP自身抗体和aPL的频率和临床意义.
- 探索这些抗体,疾病活动和血栓栓塞事件的发生之间的关联.
主要方法:
- 来自89名SLE患者的血清样本的回顾性分析,按疾病活性 (高与低) 分类.
- 通过间接单克隆抗体对血小板抗原 (MAIPA) 固定测定检测血小板GPIIb/IIIa,GPV和GPIb/IX自身抗体.
- 通过ELISA测量各种抗脂抗体 (aPL),包括抗β2糖蛋白1,抗心皮素和抗脂/原复合体.
主要成果:
- 在高疾病活性 (64%) 与低活性 (42%) 相比,观察到抗GP自身抗体的更高流行率.
- 抗GPV和抗GPIb/IX抗体在具有高SLE疾病活性的患者中明显更频繁.
- 抗GPV水平与SLE疾病活性得分正相关,与补充水平 (C3,C4) 负相关.
- 24名患者经历了未引起的血栓栓塞事件;多变量分析确定了抗GPV和低C3水平作为血栓形成的独立预测因素.
结论:
- 血小板特异性抗GP自身抗体在SLE患者中普遍存在,特别是在活跃的疾病阶段.
- 在此背景下以前未被研究的抗GPV抗体,以及低补充C3,是SLE中血栓事件的显著独立预测因素.
- 这些发现表明,抗GP抗体在SLE血栓形成的病理生理学中可能发挥作用,需要进一步调查.
相关概念视频
01:27Complement System
11.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:19Hypersensitivity Reactions: Immune-Complex Reactions
64
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
64
01:24Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
01:18Structure and Function of Platelets
4.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.1K